Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Scientific Reports|January 24, 2023
Resonant laser ionization and mass separation of 225AcJake D Johnson, Michael Heines, Frank Bruchertseifer, et al.
EJNMMI Radiopharmacy and Chemistry|December 18, 2024
Novel radionuclides: demand, production and distribution for translational research in EuropeMaija Radzina, Laura Saule, Edgars Mamis, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|October 22, 2021
Production cross-section measurements of proton-induced reactions on natural tantalum in the 0.3 GeV-1.7 GeV energy rangeCharlotte Duchemin, Thomas E Cocolios, Kristof Dockx, et al.
Frontiers in Medicine|June 2, 2015
Is there an interest to use deuteron beams to produce non-conventional radionuclides?Cyrille Alliot, Nadia Audouin, Jacques Barbet, et al.
Pharmaceutics|December 23, 2022
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [153Sm]Sm-DOTA-TATEKoen Vermeulen, Michiel Van de Voorde, Charlotte Segers, et al.
Frontiers in Medicine|October 29, 2021
Efficient Production of High Specific Activity Thulium-167 at Paul Scherrer Institute and CERN-MEDICISReinhard Heinke, Eric Chevallay, Katerina Chrysalidis, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2024
Target Development towards First Production of High-Molar- Activity 44gSc and 47Sc by Mass Separation at CERN-MEDICISEdgars Mamis, Charlotte Duchemin, Valentina Berlin, et al.
Frontiers in Medicine|May 10, 2021
Production of Mass-Separated Erbium-169 Towards the First Preclinical in vitro InvestigationsZeynep Talip, Francesca Borgna, Cristina Müller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2021
Production and Supply of α-Particle-Emitting Radionuclides for Targeted α-TherapyValery Radchenko, Alfred Morgenstern, Amir R Jalilian, et al.
Pageof 3